Nature's BioCeuticals Denmark ApS: Financial statements 2024
CVR: 41912367
Source: annual report 2024, Danish Business Authority
01/07/2023 – 30/06/2024
Nature's BioCeuticals Denmark ApS (CVR 41912367) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -400,403 and a net result of DKK -897,649 compared with DKK -1,434,890 the year before. Equity in the 2024 report amounted to DKK -2,049,699.
- Gross Profit
- DKK -400,403
- Profit/Loss
- DKK -897,649
- Equity
- DKK -2,049,699
- Total Assets
- DKK 13,670,679
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -400K | -898K | -2M | - |
| 2023 | - | -849K | -1.4M | -1.2M | - |
| 2022 | - | -944K | -1.5M | -1.5M | - |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
As of September 19, 2024, Francois Jean Martin Susini is registered as director of Nature's BioCeuticals Denmark ApS.
As of August 30, 2024, Francois Jean Martin Susini has stepped down as adm. dir. of Nature's BioCeuticals Denmark ApS.
About Nature's BioCeuticals Denmark ApS
Nature's BioCeuticals Denmark ApS is a Danish company of the type Anpartsselskab based in Odense M, founded in 2020. The company is registered under the industry Fremstilling af farmaceutiske råvarer. The company was previously named Egehoj Development ApS. The management consists of Francois Jean Martin Susini. The company is owned by Green Vault Group. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -129,477 and a net result of DKK -611,024 compared with DKK -897,649 the year before. Equity in the 2025 report amounted to DKK 12,151,659.